Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $5,716.5M | $7,119.6M | $8,088.2M | $9,139.0M | $11.2B | $10.9B | $12.0B | $13.7B | $13.4B | $14.1B | $17.3B | $17.0B | $18.8B | $20.1B | $19.5B | $19.6B | $20.4B | $20.8B | $20.4B | $21.0B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Fresenius Medical Care AG & Co. KGaA's last 12-month Revenue is $20.9B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Fresenius Medical Care AG & Co. KGaA's Revenue growth was 0.5%. The average annual Revenue growth rates for Fresenius Medical Care AG & Co. KGaA have been 0.6% over the past three years, 1.5% over the past five years.
Over the last year, Fresenius Medical Care AG & Co. KGaA's Revenue growth was 0.5%, which is higher than industry growth of 0.0%. It indicates that Fresenius Medical Care AG & Co. KGaA's Revenue growth is Good.